Expression of GD2 ganglioside by untreated primary human neuroblastomas. 1986

Z L Wu, and E Schwartz, and R Seeger, and S Ladisch

Primary neuroblastomas obtained before therapy from 36 patients were studied to determine the frequency of tumors expressing a specific glycosphingolipid, GD2 ganglioside. Total tissue gangliosides were purified by a new partition method, quantitated, and analyzed by high-performance thin-layer chromatography. All 36 neuroblastoma tumors, representing all clinical stages, contained GD2 ganglioside. The mean relative and absolute concentrations of GD2 were substantial (12% of the total tissue gangliosides and 50 nmol/g of tissue) and were independent of the clinical stage of the tumor. In contrast, 6 samples of related but more differentiated tumors (ganglioneuroblastoma and ganglioneuroma) had little or no detectable GD2 (less than or equal to 1.5% of total gangliosides and less than or equal to 4 nmol/g of tissue). These results suggest that GD2 is a sensitive marker for neuroblastoma tissue and may be an excellent target antigen for immunotherapy of this tumor.

UI MeSH Term Description Entries
D009447 Neuroblastoma A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51) Neuroblastomas
D009463 Neuroma A tumor made up of nerve cells and nerve fibers. (Dorland, 27th ed) Neuromas
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
January 2020, Biomeditsinskaia khimiia,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
January 1989, Cancer immunology, immunotherapy : CII,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
November 1984, Journal of clinical & laboratory immunology,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
April 2018, International journal of oncology,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
January 2005, Clinical neuropathology,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
August 1984, European journal of cancer & clinical oncology,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
February 1985, Biochemical and biophysical research communications,
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
December 1981, Biomedicine / [publiee pour l'A.A.I.C.I.G.],
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
October 1997, European journal of cancer (Oxford, England : 1990),
Z L Wu, and E Schwartz, and R Seeger, and S Ladisch
November 1993, International journal of oncology,
Copied contents to your clipboard!